<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03011931</url>
  </required_header>
  <id_info>
    <org_study_id>15-007568</org_study_id>
    <nct_id>NCT03011931</nct_id>
  </id_info>
  <brief_title>Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]</brief_title>
  <official_title>Simvastatin Metabolism as a Test for Celiac Disease Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the correlation between simvastatin metabolism by the enterocyte and the histologic
      state of the intestine in treated celiac disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cross sectional design incorporating subjects with active celiac disease and healed celiac
      disease (based on clinically-obtained biopsies); and healthy individuals.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare simvastatin metabolism with intestinal biopsies</measure>
    <time_frame>Within one month of visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Villous height and crypt depth</measure>
    <time_frame>Within 1 month of visit</time_frame>
    <description>As measured in intestinal biopsies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary interview</measure>
    <time_frame>At initial visit</time_frame>
    <description>To determine whether the patient is strictly adherent, mostly adherent or non-adherent to a gluten-free diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinalysis</measure>
    <time_frame>Prior to administration of simvastatin and at the 3-hour mark</time_frame>
    <description>Looking for traces of gluten peptides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serologic testing</measure>
    <time_frame>Prior to administration of simvastatin</time_frame>
    <description>tTG IgA titer level determination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DNA sampling</measure>
    <time_frame>Prior to administration of simvastatin</time_frame>
    <description>Genetic testing associated with celiac disease (DQ2 and DQ8)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>Simvastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simvastatin tablet, 20 mg, one time by mouth</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin</intervention_name>
    <description>20 mg Simvastatin given, Blood draw, Urine collection, Celiac serology testing, DNA sampling, Dietary review</description>
    <arm_group_label>Simvastatin</arm_group_label>
    <other_name>Zocor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gluten-free diet for at least 1 year

          2. Clinical endoscopy within the past month

          3. Biopsies must show no villous atrophy or villous blunting

          4. Villous height to crypt depth (VHCD) ratio measurement should be 2.5:1 or greater

        Exclusion Criteria:

          1. 1st degree relative with Celiac Disease

          2. Positive tTG IgA, already on simvastatin or statin agent

          3. Unable to stop non-steroidal or anti-inflammatory drugs

          4. Prior history of GI surgery other than appendectomy or cholecystectomy

          5. Taking drugs know to inhibit or activate CYP3A4

          6. Unable to avoid food known to inhibit CYP3A4

          7. History of a reaction to statin drugs in the past

          8. Pregnant or nursing women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph A Murray, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chad Hinson</last_name>
    <phone>507-266-0237</phone>
    <email>hinson.chadrick@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carol Van Dyke</last_name>
    <phone>207-266-7842</phone>
    <email>vandyke.carol@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Van Dyke</last_name>
      <phone>507-266-7842</phone>
      <email>vandyke.carol@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Chad Hinson</last_name>
      <phone>507-266-0237</phone>
      <email>hinson.chadrick@mayo.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2016</study_first_submitted>
  <study_first_submitted_qc>January 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2017</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Joseph A. Murray, M.D.</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

